Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Cel Sci Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 73 | 78 | +5 |
| Shares | 6.59M | 7.58M | +989.9K (+15.0%) |
| Value | $17.9M | $14.5M | −$3.40M (−19.0%) |
New holders (11)
Institutions that held Cel Sci Corp at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CVI Holdings, LLC | 878,767 | $1.68M | 1.58% |
| Millennium Management LLC | 69,678 | $133.1K | 0.00% |
| Gsa Capital Partners LLP | 25,561 | $49.0K | 0.00% |
| Stifel Financial Corp | 20,000 | $38.2K | 0.00% |
| XTX Topco Ltd | 16,321 | $31.2K | 0.00% |
| Toroso Investments, LLC | 13,891 | $26.5K | 0.00% |
| Two Sigma Securities, LLC | 11,570 | $22.1K | 0.00% |
| Squarepoint Ops LLC | 11,315 | $21.6K | 0.00% |
| Providence Wealth Advisors, LLC | 10,330 | $18.1K | 0.02% |
| Cornerstone Planning Group LLC | 575 | $938 | 0.00% |
| NBC Securities, Inc. | 19 | – | – |
Sold out (6)
Institutions that held Cel Sci Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Bank of New York Mellon Corp | 26,896 | $73.2K |
| Y-Intercept (Hong Kong) Ltd | 16,660 | $45.3K |
| Latitude Advisors, LLC | 16,170 | $44.0K |
| MML Investors Services, LLC | 10,000 | $27.0K |
| FMR LLC | 302 | $822 |
| Advisory Services Network, LLC | 300 | $816 |